Análisis de supervivencia a corto y largo plazo del hepatocarcinoma tratado mediante resección o trasplante hepático

  1. MAGADÁN ÁLVAREZ, CRISTINA
unter der Leitung von:
  1. Juan Carlos Rodríguez Sanjuán Doktorvater/Doktormutter

Universität der Verteidigung: Universidad de Cantabria

Fecha de defensa: 21 von April von 2023

Gericht:
  1. Luis Muñoz Bellvís Präsident/in
  2. Fernando Luis Hernanz de la Fuente Sekretär/in
  3. Andrés Valdivieso López Vocal

Art: Dissertation

Teseo: 801633 DIALNET lock_openTESEO editor

Zusammenfassung

Hepatocellular carcinoma is the most common primary liver tumor. It is the third cause of death from neoplasia and the first in cirrhotic patients. In early stages, curative treatment is indicated, including surgery (liver resection or liver transplantation) or ablative techniques. Liver resection is the treatment of choice for tumor lesions in non-cirrhotic livers. In cirrhotic patients, liver transplantation is preferred due to its resolution of both tumor disease and the underlying disease. In the present study, mortality, recurrence, overall, specific and disease-free survival of patients with hepatocellular carcinoma treated by liver resection or liver transplantation are analyzed and compared along 10 years in a tertiary referral hospital.